Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Kindler HL, Friberg G, Singh DA, Locker G, Nattam S, Kozloff M, Taber DA, Karrison T, Dachman A, Stadler WM, Vokes EE.
Kindler HL, et al. Among authors: stadler wm.
J Clin Oncol. 2005 Nov 1;23(31):8033-40. doi: 10.1200/JCO.2005.01.9661.
J Clin Oncol. 2005.
PMID: 16258101
Clinical Trial.